If you are a shareholder who purchased Allergan securities during the Class Period you have until January 3, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. To discuss this action please contact James E. Cecchi or Donald A. Ecklund at (973) 994–1700 or firstname.lastname@example.org.
Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C. has long been recognized as one of the leading New Jersey law firms and has significant experience in complex litigation, federal class action litigation, intellectual property, corporate, health care, public financing, environmental, labor, tax and administrative law. For additional information see http://www.carellabyrne.com/.
Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C.
James E. Cecchi
Donald A. Ecklund
5 Becker Farm Road
Roseland, New Jersey 07068-1739
(973) 994 – 1700
(973) 994 – 1744 (fax)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/class-action-lawsuit-filed-in-the-united-states-district-court-for-the-district-of-new-jersey-against-allergan-plc-on-behalf-of-shareholders-assigned-to-judge-susan-d-wigenton-and-magistrate-judge-leda-dunn-wettre--lead-plaintif-300384131.html
SOURCE Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C.